| Literature DB >> 19662168 |
Steven Garvis1, Antje Munder, Geneviève Ball, Sophie de Bentzmann, Lutz Wiehlmann, Jonathan J Ewbank, Burkhard Tümmler, Alain Filloux.
Abstract
Pseudomonas aeruginosa is an opportunistic human pathogen that causes infections in a variety of animal and plant hosts. Caenorhabditis elegans is a simple model with which one can identify bacterial virulence genes. Previous studies with C. elegans have shown that depending on the growth medium, P. aeruginosa provokes different pathologies: slow or fast killing, lethal paralysis and red death. In this study, we developed a high-throughput semi-automated liquid-based assay such that an entire genome can readily be scanned for virulence genes in a short time period. We screened a 2,200-member STM mutant library generated in a cystic fibrosis airway P. aeruginosa isolate, TBCF10839. Twelve mutants were isolated each showing at least 70% attenuation in C. elegans killing. The selected mutants had insertions in regulatory genes, such as a histidine kinase sensor of two-component systems and a member of the AraC family, or in genes involved in adherence or chemotaxis. One mutant had an insertion in a cheB gene homologue, encoding a methylesterase involved in chemotaxis (CheB2). The cheB2 mutant was tested in a murine lung infection model and found to have a highly attenuated virulence. The cheB2 gene is part of the chemotactic gene cluster II, which was shown to be required for an optimal mobility in vitro. In P. aeruginosa, the main player in chemotaxis and mobility is the chemotactic gene cluster I, including cheB1. We show that, in contrast to the cheB2 mutant, a cheB1 mutant is not attenuated for virulence in C. elegans whereas in vitro motility and chemotaxis are severely impaired. We conclude that the virulence defect of the cheB2 mutant is not linked with a global motility defect but that instead the cheB2 gene is involved in a specific chemotactic response, which takes place during infection and is required for P. aeruginosa pathogenicity.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19662168 PMCID: PMC2714965 DOI: 10.1371/journal.ppat.1000540
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Figure 1Chemotaxis Clusters in P. aeruginosa PAO1.
Cluster numbers are indicated to the left. Gene names are indicated below each representative arrow bar and PA numbers (http://pseudomonas.com) are indicated above the arrow bars. Homologues are indicated by shared color.
Identification and characterization of selected mutants.
| ORF/STM mutant | Function | Gene name | Slow killing | Cell Adherence | Swimming | Swarming |
| PA0173/ | probable methylesterase for chemotaxis |
|
|
|
|
|
| PA0260/ | hypothetical protein |
|
|
|
| |
| PA0946/ | hypothetical protein |
|
|
|
| |
| PA2478/ | probable thiol∶disulfide interchange protein |
|
|
|
|
|
| PA2585/ | endonuclease UvrABC subunit C |
|
|
|
|
|
| PA2588/ | probable transcriptional regulator |
|
|
|
| |
| PA2769/ | hypothetical protein |
|
|
|
| |
| PA3080/ | hypothetical protein |
|
|
|
| |
| PA4380/ | probable histidine kinase sensor |
|
|
|
|
|
| PA4554/ | type 4 fimbrial biogenesis protein |
|
|
|
|
|
| PA4953/ | flagellar motor protein |
|
|
|
|
|
| PA5479/ | proton-glutamate symporter |
|
|
|
|
|
ORF PA number, function and gene name annotations were obtained using the Pseudomonas genome database version 2 (http://v2.pseudomonas.com/index.jsp).
+ indicates that the strain exhibited a phenotype not significantly different from the wild type TB isolate, whereas − indicates a reduced phenotype. +/− indicates a reduction at the limit of significance.
Figure 2Swimming and Swarming Motility of TB and Isogenic Mutants.
(A) Swimming motility. The cheB2 mutant (TB0173s) shows reduced motility as compared to the parental strain (TB) whereas complementation with CTXp2B2 (TB0173sp2B2) fully restores motility. The non-complemented cheB2 mutant strain carrying CTX1 (TB0173sCTX) remains poorly motile. The cheB1 mutant (TB1549i) displays greater motility defect as compared to the cheB2 mutant. Colony area representing the motility zone was calculated using Macnification software (Orbicule BVBA Heverlee, Belgium). TB; 15,92 cm2, TB0173s (cheB2 mutant); 2,58 cm2, TB0173sp2B2 (complemented cheB2 mutant); 14,25 cm2, TB0173CTX (cheB2 mutant); 1,0 cm2, TB1549i (cheB1 mutant); 0,48 cm2. (B) Swarming motility. The cheB2 mutants (TB0173s and TB0173i) display slightly reduced motility as compared to the parental strain (TB), whereas the cheB1 mutant (TB1549i) shows a drastic swarming motility defect. (C) Swarming motility of the cheB2 mutant (TB0173s) is restored to wild-type strain (TB) level upon introduction of the CTXp2B2 (TB0173sp2B2), whereas the cheB2 mutant strain carrying an empty CTX1 (TB0173sCTX) does not display a similar motility restoration.
Figure 3C. elegans Slow Killing Assay.
(A) C. elegans survival assay comparison between the parental strain TB, the original cheB2 mutant from the STM library (TB0173s) and the reengineered cheB2 insertion mutant (TB0173i). (B) Comparison between, TB0173s (cheB2 mutant), TB0173sCTX (cheB2 mutant harboring CTX1), TB0173sp2B2 (complemented cheB2 mutant after chromosomal integration of CTXp2B2 carrying the wild type cheB2 gene) and the parental strain (TB). (C) Comparison between, the parental strain TB, the original cheB2 mutant (TB0173s) and the engineered cheB1 mutant (TB1459i). The percent of nematode survival (y axis) is shown with respect to the number of days post-infection (x axis).
Figure 4Mouse Lung Infection with P. aeruginosa TB and Mutant cheB2.
Panels A–B show the outcome of a representative single infection experiment with groups of 10 mice each. The impact on virulence of the parental TB, the cheB2 mutant TB0173s or the complemented cheB2 mutant TB0173sp2B2 isolate in a mouse lung infection model was tested. (A) The TB parental strain showed a maximal killing rate 5 days post-infection while the cheB2 mutant strain TB0173s is severely impaired for virulence. The complemented strain, TB0173sp2B2, like the parental TB isolate, is fully virulent and reaches a maximal killing by day 3. Dashed line indicates the LD50. (B) Mouse body condition and behavior was evaluated following infection. While the mice infected with the cheB2 mutant TB0173s, showed a generally untroubled condition throughout the experiment, the mice infected with the parental strain or the complemented cheB2 mutant strain (TB0173sp2B2) experienced much more severe dysfunction in condition and behavior.
Figure 5Pathohistological Signs of Inflammation in Murine Lungs.
Two days after intratracheal infection with P. aeruginosa TB or the cheB2 mutant TB0173s, mice were sacrificed. Inflammatory infiltrates are marked by arrows; b: bronchus, v: vessel. (A) TB shows a strong purulent inflammation with intra- and peribronchiolar infiltrates of leucocytes. (B) Slight peribronchiolar and perivascular inflammation is seen with the cheB2 mutant TB0173s. (C) The complemented strain TB0173sp2B2, like the wild type TB isolate, shows a strong purulent inflammation with intra- and peribronchiolar infiltrates of leucocytes. (D) The vehicle control was instilled with 30 µl PBS. Magnification×200.
Strains and plasmids used in this study.
| Strains/Plasmids | Relevant characteristics* | Reference/origin |
|
| ||
| TG1 |
| Lab. collection |
| TOP10F′ | F′ [ | Invitrogen |
| S17 λpir |
| Lab. collection |
| OP50 | Uracil auxotroph | CGC |
|
| ||
| PA14 | Wild type | Lab. collection |
| TBCF10839 (TB) | CF airway wild type, serotype 4 | Lab. collection |
| TB5479s | Tn mutant from the TB STM library, |
|
| TB4953s | Tn mutant from the TB STM library, |
|
| TB4554s | Tn mutant from the TB STM library, |
|
| TB4380s | Tn mutant from the TB STM library, |
|
| TB3080s | Tn mutant from the TB STM library, |
|
| TB2769s | Tn mutant from the TB STM library, |
|
| TB2588s | Tn mutant from the TB STM library, |
|
| TB2585s | Tn mutant from the TB STM library, |
|
| TB2478s | Tn mutant from the TB STM library, |
|
| TB0946s | Tn mutant from the TB STM library, |
|
| TB0260s | Tn mutant from the TB STM library, |
|
| TB0173s | Tn mutant from the TB STM library, |
|
| TB0173i |
| This study |
| TB1459i |
| This study |
| TB0173sCTX | TB0173s harboring CTX1 on the chromosome, Tcr | This study |
| TB0173sp2B2 | TB0173s harboring CTXp2B2 on the chromosome. CTXp2B2 encodes | This study |
| PA140173i |
| This study |
|
| ||
| pCR2.1 | Apr, ColE1 f1 | Invitrogen |
| pCR0173 | pCR2.1 vector with | This study |
| pCR1459 | pCR2.1 vector with | This study |
| Mini-CTX1 | Tcr, |
|
| Mini-CTXp2B2 | Tcr, Mini-CTX1 with | This study |
Apr, Ampicillin resistance; Cbr, Carbenicillin resistance; Gmr, Gentamycin resistance; Tcr, Tetracycline resistance.
Oligonucleotides used in this study.
| Oligonucleotide name | Sequence | Position |
| IR1f |
| 130 bp downstream from the IR upstream Gmr in pTnMod-OGm |
| IR1r |
| 100 bp upstream of the IR upstream |
| CheIN1 |
| 120 bp downstream from the |
| CheIN2 |
| 260 bp upstream from the |
| ChebUP |
| 100 bp upstream of the |
| ChebDW |
| 24 bp downstream the |
| Che1INU |
| 131 bp downstream from the |
| Che1INR |
| 363 bp upstream from the |
| Che1UP |
| 154 bp upstream of the |
| Che1DW |
| 115 bp downstream the |
| B2CTX1 |
| 393 bp upstream of the |
| B2CTX2 |
| 35 bp downstream of the |
| B2CTX3 |
| 130 bp upstream of the |
| B2CTX4 |
| 100 bp downstream of the |
*: Gmr: Gentamycin resistance cassette.
restriction sites within oligonucleotides are with italics.